Repeated intravitreal injections of antivascular endothelial growth factors and risk of intraocular pressure medication use-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Repeated intravitreal injections of antivascular endothelial growth factors and risk of intraocular pressure medication use

Published:2019-05-31 Issue:9 Volume:257 Page:1931-1939
ISSN:0721-832X
Container-title:Graefe's Archive for Clinical and Experimental Ophthalmology
language:en
Short-container-title:Graefes Arch Clin Exp Ophthalmol

Author:

Cui Qi N.,Gray Iga N.,Yu Yinxi,VanderBeek Brian L.^ORCID

Funder

National Institutes of Health

National Eye Institute

Perelman School of Medicine, University of Pennsylvania

Research to Prevent Blindness

Paul MacKall and Evanina Bell MacKall Trust

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology

Link

http://link.springer.com/content/pdf/10.1007/s00417-019-04362-7.pdf

Reference41 articles.

1. Rosenfeld PJ, Brown DM, Heier JS et al (2006) Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355(14):1419–1431

2. Brown DM, Kaiser PK, Michels M et al (2006) Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 355(14):1432–1444

3. Group CR, Martin DF, Maguire MG et al (2011) Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med 364(20):1897–1908

4. Kim JE, Mantravadi AV, Hur EY, Covert DJ (2008) Short-term intraocular pressure changes immediately after intravitreal injections of anti-vascular endothelial growth factor agents. Am J Ophthalmol 146(6):930–4 e1

5. Bakri SJ, Pulido JS, McCannel CA et al (2009) Immediate intraocular pressure changes following intravitreal injections of triamcinolone, pegaptanib, and bevacizumab. Eye (Lond) 23(1):181–185

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Intra-Retinal Fluids on Changes in Retinal Ganglion Cell and Nerve Fiber Layers in Neovascular AMD under Anti-VEGF Therapy;Journal of Clinical Medicine;2024-09-08

2. Development of dual drug loaded-hydrogel scaffold combining microfluidics and coaxial 3D-printing for intravitreal implantation;International Journal of Pharmaceutics;2024-09

3. Adverse events associated with brolucizumab: a disproportionality analysis of the FDA adverse event reporting system (FAERS);Expert Opinion on Drug Safety;2024-02-27

4. Exploring the Relationship between Anti-VEGF Therapy and Glaucoma: Implications for Management Strategies;Journal of Clinical Medicine;2023-07-14

5. RISK FACTORS FOR SURGERY OR BLINDNESS IN NEOVASCULAR GLAUCOMA EYES TREATED WITH ANTI-VEGF INJECTIONS BY A RETINA SPECIALIST;Retina;2023-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3